# A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin

> **NCT04706637** · PHASE4 · UNKNOWN · sponsor: **Kyung Hee University Hospital at Gangdong** · enrollment: 120 (estimated)

## Conditions studied

- Bone Diseases, Metabolic
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Evogliptin
- **DRUG:** Dapagliflozin

## Key facts

- **NCT ID:** NCT04706637
- **Lead sponsor:** Kyung Hee University Hospital at Gangdong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-01
- **Primary completion:** 2022-01-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2021-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04706637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04706637, "A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04706637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*